Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 8931508, 8 pages
http://dx.doi.org/10.1155/2016/8931508
Research Article

Risk Factors for Foot Amputation in Patients Hospitalized for Diabetic Foot Infection

1Pontifícia Universidade Católica de São Paulo, Sorocaba, SP, Brazil
2University of Sorocaba, Rodovia Raposo Tavares, Km 92,5, 18023-000 Sorocaba, SP, Brazil
3Universidade de Brasília, Brasília, DF, Brazil

Received 28 July 2015; Revised 4 January 2016; Accepted 27 January 2016

Academic Editor: Edward Jude

Copyright © 2016 Maria Teresa Verrone Quilici et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Bakker and N. C. Schaper, “The development of global consensus guidelines on the management and prevention of the diabetic foot 2011,” Diabetes/Metabolism Research and Reviews, vol. 28, supplement 1, pp. 116–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Brechow, T. Slesaczeck, D. Münch et al., “Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease,” Therapeutic Advances in Endocrinology and Metabolism, vol. 4, no. 3, pp. 83–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Gordois, P. Scuffham, A. Shearer, A. Oglesby, and J. A. Tobian, “The health care costs of diabetic peripheral neuropathy in the U.S.,” Diabetes Care, vol. 26, no. 6, pp. 1790–1795, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. K. F. Rezende, M. B. Ferraz, D. A. Malerbi et al., “Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country—a simulation of the current situation in Brazil,” Diabetic Medicine, vol. 27, no. 1, pp. 109–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. I. C. R. V. Santos, C. M. M. Sobreira, É. N. D. S. Nunes, and M. C. D. A. Morais, “The prevalence and factors associated with diabetic foot amputations,” Ciencia e Saude Coletiva, vol. 18, no. 10, pp. 3007–3014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Van Battum, N. Schaper, L. Prompers et al., “Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation,” Diabetic Medicine, vol. 28, no. 2, pp. 199–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Pscherer, F.-W. Dippel, S. Lauterbach, and K. Kostev, “Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany,” Primary Care Diabetes, vol. 6, no. 3, pp. 241–246, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Weck, T. Slesaczeck, H. Paetzold et al., “Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates,” Cardiovascular Diabetology, vol. 12, article 45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Shojaiefard, Z. Khorgami, and B. Larijani, “Independent risk factors for amputation in diabetic foot,” International Journal of Diabetes in Developing Countries, vol. 28, no. 2, pp. 32–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Van Olmen, K. G. Marie, D. Christian et al., “Content, participants and outcomes of three diabetes care programmes in three low and middle income countries,” Primary Care Diabetes, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Quddus and M. J. Uddin, “Evaluation of foot ulcers in diabetic patients,” Mymensingh Medical Journal, vol. 22, no. 3, pp. 527–532, 2013. View at Google Scholar · View at Scopus
  12. J. S. Markowitz, E. M. Gutterman, G. Magee, and D. J. Margolis, “Risk of amputation in patients with diabetic foot ulcers: a claims-based study,” Wound Repair and Regeneration, vol. 14, no. 1, pp. 11–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Carlson and J. F. Reed III, “A case-control study of the risk factors for toe amputation in a diabetic population,” The International Journal of Lower Extremity Wounds, vol. 2, no. 1, pp. 19–21, 2003. View at Publisher · View at Google Scholar
  14. N. Chaturvedi, L. K. Stevens, J. H. Fuller, E. T. Lee, and M. Lu, “Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes,” Diabetologia, vol. 44, supplement 2, pp. S65–S71, 2001. View at Publisher · View at Google Scholar
  15. American Diabetes Association, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Publisher · View at Google Scholar
  16. W. S. Aronow, J. L. Fleg, C. J. Pepine et al., “ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension,” Journal of the American College of Cardiology, vol. 57, no. 20, pp. 2037–2114, 2011. View at Publisher · View at Google Scholar
  17. L. Norgren, W. R. Hiatt, J. A. Dormandy et al., “Inter-Society consensus for the management of peripheral arterial disease (TASC II),” International Angiology, vol. 26, no. 2, pp. 82–157, 2007. View at Google Scholar · View at Scopus
  18. P. S. Jellinger, D. A. Smith, A. E. Mehta et al., “American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis,” Endocrine Practice, vol. 18, supplement 1, pp. 1–78, 2012. View at Google Scholar · View at Scopus
  19. S. D. Fihn, J. M. Gardin, J. Abrams et al., “ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Journal of the American College of Cardiology, vol. 60, no. 24, pp. e44–e164, 2012. View at Publisher · View at Google Scholar
  20. F. W. Wagner Jr., “The dysvascular foot: a system for diagnosis and treatment,” Foot and Ankle, vol. 2, no. 2, pp. 64–122, 1981. View at Publisher · View at Google Scholar · View at Scopus
  21. D. E. Morisky, L. W. Green, and D. M. Levine, “Concurrent and predictive validity of a self-reported measure of medication adherence,” Medical Care, vol. 24, no. 1, pp. 67–74, 1986. View at Publisher · View at Google Scholar · View at Scopus
  22. F. W. Gemechu, F. Seemant, and C. A. Curley, “Diabetic foot infections,” American Family Physician, vol. 88, no. 3, pp. 177–184, 2013. View at Google Scholar · View at Scopus
  23. D. Lévigne, M. Tobalem, A. Modarressi, and B. Pittet-Cuénod, “Hyperglycemia increases susceptibility to ischemic necrosis,” BioMed Research International, vol. 2013, Article ID 490964, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Aragón-Sánchez, J. L. Lázaro-Martínez, J. Pulido-Duque, and M. Maynar, “From the diabetic foot ulcer and beyond: how do foot infections spread in patients with diabetes?” Diabetic Foot and Ankle, vol. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. S. Bortoletto, S. M. de Andrade, T. Matsuo, M. D. C. L. Haddad, A. D. González, and A. M. R. Silva, “Risk factors for foot ulcers—a cross sectional survey from a primary care setting in Brazil,” Primary Care Diabetes, vol. 8, no. 1, pp. 71–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. L. Morgan, C. J. Currie, N. C. H. Stott, M. Smithers, C. C. Butler, and J. R. Peters, “The prevalence of multiple diabetes-related complications,” Diabetic Medicine, vol. 17, no. 2, pp. 146–151, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chuengsamarn, S. Rattanamongkolgul, and S. Jirawatnotai, “Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 28, no. 2, pp. 124–129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Pradeepa, R. M. Anjana, R. Unnikrishnan, A. Ganesan, V. Mohan, and M. Rema, “Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes—the Chennai Urban Rural Epidemiology Study (CURES) eye study-5,” Diabetes Technology and Therapeutics, vol. 12, no. 10, pp. 755–761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Al-Maskari and M. El-Sadig, “Prevalence of risk factors for diabetic foot complications,” BMC Family Practice, vol. 8, article 59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Aragón-Sánchez, J. L. Lázaro-Martínez, Y. García-Álvarez, E. G. Morales, and M. J. Hernández-Herrero, “Albuminuria is a predictive factor of in-hospital mortality in patients with diabetes admitted for foot disease,” Diabetes Research and Clinical Practice, vol. 104, no. 1, pp. e23–e25, 2014. View at Publisher · View at Google Scholar
  31. M. Zubair, A. Malik, and J. Ahmad, “Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital,” Foot, vol. 22, no. 1, pp. 24–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Malik, Z. Mohammad, and J. Ahmad, “The diabetic foot infections: biofilms and antimicrobial resistance,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 7, no. 2, pp. 101–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Chung, D. A. Timaran, J. G. Modrall et al., “Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia,” Journal of Vascular Surgery, vol. 58, no. 4, pp. 972–980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. T. B. Gibson, X. Song, B. Alemayehu et al., “Cost sharing, adherence, and health outcomes in patients with diabetes,” The American Journal of Managed Care, vol. 16, no. 8, pp. 589–600, 2010. View at Google Scholar · View at Scopus
  35. M. Venermo, K. Manderbacka, T. Ikonen, I. Keskimäki, K. Winel, and R. Sund, “Amputations and socioeconomic position among persons with diabetes mellitus, a population-based register study,” BMJ Open, vol. 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Haupt, G. R. Weitoft, and J. L. G. Nilsson, “Refill adherence to oral antihyperglycaemic drugs in Sweden,” Acta Diabetologica, vol. 46, no. 3, pp. 203–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. N. Dorresteijn and G. D. Valk, “Patient education for preventing diabetic foot ulceration,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 101–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. V. P. dos Santos, D. R. da Silveira, and R. A. Caffaro, “Risk factors for primary major amputation in diabetic patients,” Sao Paulo Medical Journal, vol. 124, no. 2, pp. 66–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. S. Gonzalez, H. E. Schneider, D. J. Wexler et al., “Validity of medication adherence self-reports in adults with type 2 diabetes,” Diabetes Care, vol. 36, no. 4, pp. 831–837, 2013. View at Publisher · View at Google Scholar · View at Scopus